| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 900.83M | 902.32M | 1.01B | 819.30M | 798.11M |
| Gross Profit | 117.58M | 120.94M | 129.56M | 114.02M | 102.30M |
| EBITDA | 60.38M | 59.46M | 63.20M | 59.09M | 36.44M |
| Net Income | 22.27M | 18.88M | 22.17M | 28.07M | 12.60M |
Balance Sheet | |||||
| Total Assets | 1.01B | 1.07B | 870.32M | 799.13M | 648.81M |
| Cash, Cash Equivalents and Short-Term Investments | 52.01M | 57.86M | 42.39M | 50.46M | 62.32M |
| Total Debt | 513.25M | 498.38M | 444.34M | 413.40M | 272.19M |
| Total Liabilities | 778.86M | 845.39M | 669.17M | 620.14M | 497.89M |
| Stockholders Equity | 228.95M | 220.04M | 201.15M | 178.98M | 150.92M |
Cash Flow | |||||
| Free Cash Flow | -20.34M | 30.94M | 19.26M | -120.44M | -801.00K |
| Operating Cash Flow | -18.70M | 34.17M | 19.83M | -120.40M | 259.00K |
| Investing Cash Flow | -1.64M | -12.32M | -15.50M | -19.67M | -3.91M |
| Financing Cash Flow | 7.18M | -6.37M | -12.40M | 128.22M | 13.29M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$184.00M | 8.86 | 14.78% | 5.14% | -0.24% | -19.66% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$616.00M | 15.44 | 10.13% | 3.63% | -0.16% | 17.80% | |
60 Neutral | HK$218.07M | 8.23 | 7.09% | 1.75% | 14.72% | -26.49% | |
48 Neutral | HK$168.75M | -2.58 | 110.53% | ― | 21.30% | -40.94% | |
47 Neutral | HK$197.60M | 9.03 | 5.57% | 2.58% | 27.88% | 1.69% | |
41 Neutral | HK$449.74M | -1.15 | -14.52% | ― | 9.18% | 84.15% |